Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo

The Sponsored Research Agreement will help advance antidepressant treatments for patients in need

Previous
Previous

Psychedelic Biotech Strikes Big Pharma Agreement

Next
Next

Psylo signs research deal with Daiichi Sankyo for psychiatric therapies